We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Delays NDA Decision on Heron’s Chemo Treatment
Nivalis Therapeutics Garners Orphan Drug Status for N91115
ALK’s Asthma Prevention Therapy Whiffs on Primary Endpoint
Loxo Oncology Wins EMA Orphan Drug Designation for LOXO-101
Ohio Citizen Drug Price Initiative Moves to Federal Court